9.0
[]. D Smith, et al. A pharmacokinetic model for isosorbidedinitrate, isosorbide--mononitrate, and isosorbide-5-mononitrate. Drug Metab Dispos. 990 Jul-Aug;8(4):49-34.
[]. J E Metzner, et al. [Study of the bioequivalence of a new isosorbide dinitrate tablet formulation compared with the standard preparation]. Arzneimittelforschung. 997 Jun;47():79-.
[3]. R Atanassova, et al. Effects of isosorbide-5-mononitrate and isosorbide--mononitrate on isolated dog aorta: vascular relaxation and increase in cyclic GMP. Arch Int Pharmacodyn Ther. 99 Jul-Aug:3:04-9.
[4]. R Atanassova, et al. Effects of isosorbide-5-mononitrate and isosorbide--mononitrate on the contractile and electrical activity and on the content of cyclic nucleotides in isolated heart muscles of the guinea-pig and dog. J Pharm Pharmacol. 99 Aug;44(8):3-.
[5]. Riccardo Raddino, et al. Differences between nitrates: role of isosorbide -mononitrate. J Cardiovasc Med (Hagerstown). 00 Jul;(7):48-9.
H4-H30
P0-P34-P35-P40-P4-P70-P80-P330-P370+P378-P403-P40-P50